CBD and US Law

The legal availability of CBD in other US states is often challenged, but what is certain is that natural cannabinoids found in hemp are specifically exempt from the Controlled Substances Act. Since natural cannabinoids are found in all hemp products, and hemp products are found on grocery store shelves nationwide, hemp oils would appear to be the easiest, legal manner in which to obtain CBD.

Products made from hemp are found in retail stores nationwide, thanks to a federal exemption to the definition of “marijuana”. 

Since 1937, the federal statute controlling “marijuana” has excluded the mature stalks, fiber, oil, and any other preparation of the mature stalks of Cannabis sativa L., commonly known as “hemp”, from the definition of “marijuana.”

When the Hemp Industries Association defended hemp’s exempt status in 2004, the DEA declined to challenge this ruling, which is why there continues to be a wide variety of hemp products on the market today. Walk into many retail and grocery stores and you will find hemp protein powder, hemp seeds, hemp clothing, and hemp oil.

Leave us not forget... 

PubMed

• Safety and side effects of cannabidiol, a Cannabis sativa constituent (PubMed)
• Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action(PubMed)
• Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (PubMed)
• Cannabidiol: An overview of some pharmacological aspects (PubMed)
• Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: chemical aspects (PubMed)
• The endocannabinoid system as an emerging target of pharmacotherapy (PubMed)
• Therapeutic potential of cannabinoid-based drugs (PubMed)
• Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities (PubMed)
• Cannabis-based medicines–GW pharmaceuticals: High CBD, high THC, medicinal cannabis–GW pharmaceuticals, THC:CBD (PubMed)
• The therapeutic potential of cannabis and cannabinoids (PubMed)
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines(PubMed)
• Therapeutic potential of cannabinoid-based drugs (PubMed)
• Cannabinoids in clinical practice (PubMed)
• Cannabinoids (PubMed)
• Pharmacology of cannabinoids (PubMed)
• Combined cannabinoid therapy via an oromucosal spray (PubMed)
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb (PubMed)
• Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology (PubMed)
• Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system (PubMed)
• Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants (PubMed)
• A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (PubMed)
• Clinical Studies With Cannabis and Cannabinoids, 2005-2009 (O’Shaughnessy’s)